What is HyaCera and how is it different from topical ceramide products?

HyaCera is an oral supplement combining 350mg wheat oil extract (a ceramide precursor) and 120mg low-molecular-weight sodium hyaluronate (300~400kDa). Unlike topical ceramides that work on the surface, oral ceramide precursors are absorbed through digestion and may support ceramide synthesis from within the skin's outermost layer.

How strong is the evidence from this trial?

It was a randomized, double-blind, placebo-controlled trial with 63 participants over 12 weeks, one of the most rigorous designs used in supplement research. Zero adverse events were reported. The study was funded by Ritual, the supplement's maker, which is worth noting when interpreting the results.

When does hyaluronic acid work better, applied topically or taken orally?

Both have roles. Topical HA works at the surface to temporarily hydrate and plump. Oral low-molecular HA (under 400kDa) may be absorbed through the gut and stimulate HA synthesis in the dermis, the deeper skin layer where structural moisture is maintained. Several studies support the oral route for longer-term elasticity benefits.

An Oral Skin Supplement Reduced Crow's Feet in 12 Weeks

Eating your skincare is no longer just a wellness trend talking point. A 12-week randomized, double-blind, placebo-controlled trial published in Dermatology and Therapy (Springer Nature) found that a daily oral supplement combining wheat ceramide and low-molecular hyaluronic acid produced statistically significant improvements in crow’s feet wrinkles and skin elasticity, starting at week 8.

Who Was in the Study

63 adults between the ages of 26 and 64 participated, with a mean age of 45.7. The group was 85.7% female and racially diverse: 50.8% White, 33.3% Black, 9.5% Asian. Participants were randomized to either HyaCera™ (31 people) or an identical-looking placebo (32 people) for 12 weeks. Neither the participants nor the researchers knew who received which, the hallmark of a true double-blind design.

Each HyaCera™ capsule contains 350mg of wheat oil extract, a source of sphingolipids that serve as ceramide precursors, and 120mg of sodium hyaluronate with a molecular weight of 300~400kDa. The low molecular weight is intentional: smaller HA fragments are more readily absorbed through the gut wall compared to the larger molecules found in most topical products.

What Changed at Week 8

The most immediate signal came from crow’s feet measurements. Compared to placebo, the intervention group showed statistically significant reduction by week 8 (F=4.96, p<0.05). Skin smoothness improved across weeks 8 through 12 at a similar significance level (F=5.62, p<0.05). Skin elasticity measured by the R2 parameter improved with p<0.01 in the supplement group, compared to a statistically insignificant p=0.14 in placebo.

Dermatologist assessments confirmed: deep wrinkles decreased (p<0.01) and fine wrinkles showed improvement (p<0.05). On the self-reported side, participants felt meaningful improvement in resilience and elasticity (chi-squared 8.47, p<0.01). Over the 12-week period, zero adverse events were recorded, and 80.6% of completers said they would continue taking the supplement.

How Oral Ceramides Actually Work

Topical ceramides patch the skin barrier from outside. Oral ceramides follow a different path. The sphingolipids from wheat oil are broken down during digestion into fatty acids and sphingoid bases. These travel through the bloodstream and are thought to serve as building blocks that stimulate ceramide synthesis within the stratum corneum, the outermost layer of skin responsible for barrier function and moisture retention.

For hyaluronic acid, the mechanism is similar: low-molecular fragments survive digestion, enter circulation, and may upregulate HA production in the dermis, the connective layer beneath the surface where skin structural integrity is maintained.

The 12-week duration also matters here. Human skin undergoes a complete cell turnover cycle roughly every 28 days. Seeing measurable results after more than three full cycles suggests the changes are structural rather than transient.

One important note: this study was funded by Ritual, the company that makes HyaCera™. The design is solid, but independent replication would strengthen the case further. What stands out is that among oral skincare clinical trials, this one meets a higher methodological bar than most.

Source: Dermatology and Therapy / Springer Nature